A.M.J. Wever

707 total citations
16 papers, 531 citations indexed

About

A.M.J. Wever is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, A.M.J. Wever has authored 16 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 3 papers in Immunology and Allergy. Recurrent topics in A.M.J. Wever's work include Asthma and respiratory diseases (9 papers), Respiratory and Cough-Related Research (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). A.M.J. Wever is often cited by papers focused on Asthma and respiratory diseases (9 papers), Respiratory and Cough-Related Research (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). A.M.J. Wever collaborates with scholars based in Netherlands, Sweden and Italy. A.M.J. Wever's co-authors include J. Hermans, J.W.H. Leer, Evert M. Noordijk, Chris van Weel, J.M. Kouwenberg, E. J. Duiverman, J Hermans, Joop H. Dijkman, W. Bakker and Cees L. A. van Herwaarden and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and European Respiratory Journal.

In The Last Decade

A.M.J. Wever

16 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A.M.J. Wever Netherlands	12	398	225	66	61	50	16	531
Shane Hanon Belgium	14	477 1.2×	257 1.1×	12 0.2×	53 0.9×	75 1.5×	33	665
Eve Denton Australia	10	297 0.7×	301 1.3×	54 0.8×		48 1.0×	27	503
David J. Valacer United States	8	267 0.7×	326 1.4×	46 0.7×		38 0.8×	15	485
H Joyce United Kingdom	11	430 1.1×	330 1.5×	47 0.7×		36 0.7×	20	551
Francis Nissen Switzerland	11	272 0.7×	306 1.4×	48 0.7×		15 0.3×	27	566
M. Tunon de Lara France	6	363 0.9×	262 1.2×	49 0.7×	2 0.0×	4 0.1×	12	453
Eva Martínez-Moragón Spain	11	415 1.0×	192 0.9×	51 0.8×		21 0.4×	17	521
Charlotte Colp United States	13	243 0.6×	162 0.7×	10 0.2×		29 0.6×	24	407
Mathew Ninan United States	10	363 0.9×	36 0.2×	2 0.0×	18 0.3×	46 0.9×	21	661
Megan Hardin United States	15	832 2.1×	716 3.2×	32 0.5×	1 0.0×	12 0.2×	44	1.0k

Countries citing papers authored by A.M.J. Wever

Since Specialization

Citations

This map shows the geographic impact of A.M.J. Wever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M.J. Wever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M.J. Wever more than expected).

Fields of papers citing papers by A.M.J. Wever

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.M.J. Wever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M.J. Wever. The network helps show where A.M.J. Wever may publish in the future.

Co-authorship network of co-authors of A.M.J. Wever

This figure shows the co-authorship network connecting the top 25 collaborators of A.M.J. Wever. A scholar is included among the top collaborators of A.M.J. Wever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.M.J. Wever. A.M.J. Wever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Wever, A.M.J., et al.. (2016). Prevalence and awareness of functional and structural foot abnormalities in children and adolescents with type 1 diabetes. Journal of Pediatric Endocrinology and Metabolism. 29(9). 1019–24. 2 indexed citations

Löwhagen, O., A.M.J. Wever, Mirco Lusuardi, et al.. (2002). The inflammatory marker serum eosinophil cationic protein (ECP) compared with PEF as a tool to decide inhaled corticosteroid dose in asthmatic patients. Respiratory Medicine. 96(2). 95–101. 23 indexed citations

Kouwenberg, J.M., et al.. (2000). Risk factors for exacerbations and hospital admissions in asthma of early childhood. Pediatric Pulmonology. 29(4). 250–256. 54 indexed citations

Kouwenberg, J.M., et al.. (1999). Prognostic characteristics of asthma diagnosis in early childhood in clinical practice. Acta Paediatrica. 88(8). 827–834. 26 indexed citations

Cheung, David W., et al.. (1998). Effects of Theophylline on Tolerance to the Bronchoprotective Actions of Salmeterol in Asthmatics In Vivo. American Journal of Respiratory and Critical Care Medicine. 158(3). 792–796. 16 indexed citations

Wever, A.M.J., et al.. (1997). Asthma statistics in the Netherlands 1980–1994. Respiratory Medicine. 91(7). 417–422. 19 indexed citations

Wever, A.M.J., et al.. (1993). Testing for inhalant allergy in asthma. Clinical & Experimental Allergy. 23(12). 976–981. 10 indexed citations

Wever, A.M.J., et al.. (1991). Mortality and morbidity from respiratory diseases in childhood in The Netherlands, 1980-1987. European Respiratory Journal. 4(4). 429–433. 19 indexed citations

Schayck, Constant P. van, Edward Dompeling, Cees L. A. van Herwaarden, A.M.J. Wever, & Chris van Weel. (1991). Interacting Effects of Atopy and Bronchial Hyperresponsiveness on the Annual Decline in Lung Function and the Exacerbation Rate in Asthma. American Review of Respiratory Disease. 144(6). 1297–1301. 61 indexed citations

10.

Wever, A.M.J., et al.. (1990). Evaluation of the Phadiatop® test in an epidemiological study. Allergy. 45(2). 92–97. 32 indexed citations

11.

Wever, A.M.J., et al.. (1989). [The Phadiatop test, a new in-vitro test for inhalation allergy].. PubMed. 133(2). 70–3. 3 indexed citations

12.

Noordijk, Evert M., et al.. (1988). Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiotherapy and Oncology. 13(2). 83–89. 178 indexed citations

13.

Wever, A.M.J., et al.. (1984). Krypton-81m ventilation studies as a parameter for lung capacity after lobectomy. European Journal of Nuclear Medicine and Molecular Imaging. 9(7). 312–315. 2 indexed citations

14.

Watkins, Chris, Paul Burton, Stephen Leeder, et al.. (1982). Doctor Diagnosis and Maternal Recall of Lower Respiratory Illness. International Journal of Epidemiology. 11(1). 62–66. 20 indexed citations

15.

Dijkman, Joop H., et al.. (1982). Transpleural Lung Biopsy by the Thoracoscopic Route in Patients with Diffuse Interstitial Pulmonary Disease. CHEST Journal. 82(1). 76–83. 55 indexed citations

16.

Bakker, W., et al.. (1981). Postoperative intrapleural BCG in lung cancer: lack of efficacy and possible enhancement of tumour growth.. Thorax. 36(11). 870–874. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact